Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 444

1.
2.

Matrix metalloproteinase 9 activity leads to elastin breakdown in an animal model of Kawasaki disease.

Lau AC, Duong TT, Ito S, Yeung RS.

Arthritis Rheum. 2008 Mar;58(3):854-63. doi: 10.1002/art.23225.

3.

Inhibition of matrix metalloproteinase-9 activity improves coronary outcome in an animal model of Kawasaki disease.

Lau AC, Duong TT, Ito S, Wilson GJ, Yeung RS.

Clin Exp Immunol. 2009 Aug;157(2):300-9. doi: 10.1111/j.1365-2249.2009.03949.x.

4.

[Effects of intravenous immunoglobulin upon the overexpression and over-activation of nuclear factor-κB and matrix metalloproteinase-9 in murine model of Kawasaki disease].

Shangguan W, Du Z, Yang H, Zhang Y, Song M, Dong W.

Zhonghua Yi Xue Za Zhi. 2014 Apr 1;94(12):938-43. Chinese.

PMID:
24854917
5.

Anti-inflammatory effect of intravenous immunoglobulin in comparison with dexamethasone in vitro: implication for treatment of Kawasaki disease.

Makata H, Ichiyama T, Uchi R, Takekawa T, Matsubara T, Furukawa S.

Naunyn Schmiedebergs Arch Pharmacol. 2006 Aug;373(5):325-32. Epub 2006 Aug 1.

PMID:
16896803
6.

Expression of CD40 ligand on CD4+ T-cells and platelets correlated to the coronary artery lesion and disease progress in Kawasaki disease.

Wang CL, Wu YT, Liu CA, Lin MW, Lee CJ, Huang LT, Yang KD.

Pediatrics. 2003 Feb;111(2):E140-7.

PMID:
12563087
7.

Treatment of acute Kawasaki disease: aspirin's role in the febrile stage revisited.

Hsieh KS, Weng KP, Lin CC, Huang TC, Lee CL, Huang SM.

Pediatrics. 2004 Dec;114(6):e689-93. Epub 2004 Nov 15.

PMID:
15545617
8.

The role of atorvastatin in regulating the immune response leading to vascular damage in a model of Kawasaki disease.

Blankier S, McCrindle BW, Ito S, Yeung RS.

Clin Exp Immunol. 2011 May;164(2):193-201. doi: 10.1111/j.1365-2249.2011.04331.x. Epub 2011 Mar 1.

10.

Increased production of vascular endothelial growth factor-d and lymphangiogenesis in acute Kawasaki disease.

Ebata R, Abe J, Yasukawa K, Hamada H, Higashi K, Suwazono Y, Saito H, Terai M, Kohno Y.

Circ J. 2011;75(6):1455-62. Epub 2011 Apr 12.

11.

Gene expression profiling of the effect of high-dose intravenous Ig in patients with Kawasaki disease.

Abe J, Jibiki T, Noma S, Nakajima T, Saito H, Terai M.

J Immunol. 2005 May 1;174(9):5837-45.

12.

Treatment of Kawasaki disease with a moderate dose (1 g/kg) of intravenous immunoglobulin.

Khowsathit P, Hong-Hgam C, Khositseth A, Wanitkun S.

J Med Assoc Thai. 2002 Nov;85 Suppl 4:S1121-6.

PMID:
12549785
13.

[Effects of three intravenous gamma globulin regimens on Kawasaki disease and relevant coronary complication rates in pediatric patients: a comparative study].

DU ZD, Zhao D, DU JB, Lu S, Yi JM, Hou AC, Zhou ZS, Ding GF; Beijing Kawasaki Disease Epidemilogy Study Grou..

Zhonghua Yi Xue Za Zhi. 2007 Nov 27;87(44):3119-21. Chinese.

PMID:
18269869
14.

The effect of TNFalpha blockade in complicated, refractory Kawasaki disease.

Stenbøg EV, Windelborg B, Hørlyck A, Herlin T.

Scand J Rheumatol. 2006 Jul-Aug;35(4):318-21.

PMID:
16882598
15.

The immunologic effects of IVIG in Kawasaki disease.

Leung DY.

Int Rev Immunol. 1989;5(2):197-202. Review.

PMID:
8691053
16.

Infliximab as a novel therapy for refractory Kawasaki disease.

Weiss JE, Eberhard BA, Chowdhury D, Gottlieb BS.

J Rheumatol. 2004 Apr;31(4):808-10.

PMID:
15088313
18.

The functions of endothelial progenitor cells were significantly improved after treatment with intravenous immunoglobulin and aspirin in children with Kawasaki disease.

Xu MG, Men LN, Zu Y, Zhao CY, Meng XC, Wang T.

Pediatr Cardiol. 2011 Apr;32(4):455-60. doi: 10.1007/s00246-011-9900-4. Epub 2011 Feb 16.

PMID:
21327631
19.

Treatment of Kawasaki disease using locally product intravenous immunoglobulin.

Sangtawesin C, Kirawitaya T, Layangkool T, Nawasiri W, Vimolsarawong N.

J Med Assoc Thai. 2003 Aug;86 Suppl 3:S656-60.

PMID:
14700163
20.

Recent advances in the treatment of Kawasaki disease.

Weng KP, Ou SF, Lin CC, Hsieh KS.

J Chin Med Assoc. 2011 Nov;74(11):481-4. doi: 10.1016/j.jcma.2011.09.001. Epub 2011 Nov 4. Review.

Supplemental Content

Support Center